The Hague (AFP) May 4, 2021
Europe's medicines watchdog said Tuesday it has started reviewing China's Sinovac coronavirus jab, a process that could lead to eventual approval for the European market. Made by Sinovac's Beijing-based Life Sciences unit, the vaccine by the Chinese biotech firm is the second shot developed outside the West after Russia's Sputnik V to be considered for European use by the European Medicines
EMA opens review of China's Sinovac coronavirus jab
Terra Daily
0 shares
1 views
You might like
Related news coverage
EU regulators start review of China's Sinovac vaccine
THE HAGUE, Netherlands (AP) — The European Union’s drug regulator announced Tuesday that it has started a rolling review of..
SeattlePI.com